1 / 1

Pemphigus Vulgaris Market

<br>The total diagnosed prevalent cases of Pemphigus Vulgaris in the 7MM was 41,217 in 2017. Among 7MM, the United States accounted for the highest number of diagnosed prevalent cases of PV in 2017, while France had the lowest number of cases. <br><br>The market size of Pemphigus Vulgaris in 7MM was found to be USD 181.78 Million in 2017, which is expected to increase during the forecast period 2017-2030.<br><br>Approval of MabThera/Rituxan, increasing awareness, rising prevalence rates, updated diagnostic and treatment guidelines are some of the key factors expected to drive the PV market forward in the coming years. <br><br>The key pharma companies in the Pemphigus Vulgaris Market include Principia Biopharma, Novartis/ MorphoSys, Argenx, Topas Therapeutics, and many others.<br><br>For more detailed information on Pemphigus Vulgaris Market, visit: <br>https://www.delveinsight.com/report-store/pemphigus-vulgaris-market<br><br>#raredisease #autoimmunedisease #autoimmunedisorder #blisteringskindisease<br><br>

DelveInsight
Download Presentation

Pemphigus Vulgaris Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related